These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35433292)

  • 1. Possible relationship between refractory celiac disease and malignancies.
    Demiroren K
    World J Clin Oncol; 2022 Mar; 13(3):200-208. PubMed ID: 35433292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Nonresponsive and Refractory Celiac Disease.
    Malamut G; Soderquist CR; Bhagat G; Cerf-Bensussan N
    Gastroenterology; 2024 Jun; 167(1):132-147. PubMed ID: 38556189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific T-cell receptor beta-rearrangements of gluten-triggered CD8
    Seitz V; Gennermann K; Elezkurtaj S; Groth D; Schaper S; Dröge A; Lachmann N; Berg E; Lenze D; Kühl AA; Husemann C; Kleo K; Horst D; Lennerz V; Hennig S; Hummel M; Schumann M
    Clin Immunol; 2023 Nov; 256():109795. PubMed ID: 37769786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA Genotyping in Romanian Adult Patients with Celiac Disease, their First-degree Relatives and Healthy Persons.
    Maruntelu I; Preda CM; Sandra I; Istratescu D; Chifulescu AE; Manuc M; Diculescu M; Talangescu A; Tugui L; Manuc T; Stroie T; Andrei AC; Tieranu C; Constantinescu I
    J Gastrointestin Liver Dis; 2022 Jun; 31(2):191-197. PubMed ID: 35694992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class II genes in precision-based care of childhood diseases: what we can learn from celiac disease.
    Del Pozzo G; Farina F; Picascia S; Laezza M; Vitale S; Gianfrani C
    Pediatr Res; 2021 Jan; 89(2):307-312. PubMed ID: 33122841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring nonresponsive patients who have celiac disease.
    Krauss N; Schuppan D
    Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Therapeutic Strategies for Celiac Disease.
    Asri N; Rostami-Nejad M; Rezaei-Tavirani M; Razzaghi M; Asadzadeh-Aghdaei H; Zali MR
    Middle East J Dig Dis; 2020 Oct; 12(4):229-237. PubMed ID: 33564379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory celiac disease.
    Ryan BM; Kelleher D
    Gastroenterology; 2000 Jul; 119(1):243-51. PubMed ID: 10889175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
    Green PHR; Paski S; Ko CW; Rubio-Tapia A
    Gastroenterology; 2022 Nov; 163(5):1461-1469. PubMed ID: 36137844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiac disease: how complicated can it get?
    Tjon JM; van Bergen J; Koning F
    Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celiac disease: risk assessment, diagnosis, and monitoring.
    Setty M; Hormaza L; Guandalini S
    Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology of Celiac Disease. Position Statements of the Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC).
    Villanacci V; Ciacci C; Salviato T; Leoncini G; Bonetti LR; Ragazzini T; Limarzi F; Saragoni L
    Transl Med UniSa; 2020 Oct; 23():28-36. PubMed ID: 33457319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of celiac disease in daily clinical practice.
    Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D
    Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Risk of Malignancies in Celiac Disease-A Literature Review.
    Pelizzaro F; Marsilio I; Fassan M; Piazza F; Barberio B; D'Odorico A; Savarino EV; Farinati F; Zingone F
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.
    Cellier C; Delabesse E; Helmer C; Patey N; Matuchansky C; Jabri B; Macintyre E; Cerf-Bensussan N; Brousse N
    Lancet; 2000 Jul; 356(9225):203-8. PubMed ID: 10963198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Celiac Disease and Cancer.
    Marafini I; Monteleone G; Stolfi C
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gluten Degrading Enzymes for Treatment of Celiac Disease.
    Wei G; Helmerhorst EJ; Darwish G; Blumenkranz G; Schuppan D
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32679754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiac disease risk stratification based on HLA-DQ heterodimer (HLA-DQA1 ~ DQB1) typing in a large cohort of adults with suspected celiac disease.
    Choung RS; Mills JR; Snyder MR; Murray JA; Gandhi MJ
    Hum Immunol; 2020; 81(2-3):59-64. PubMed ID: 32005535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical manifestations of adult celiac disease].
    Malamut G; Cellier C
    Pathol Biol (Paris); 2013 Jun; 61(3):e47-51. PubMed ID: 21621928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Celiac disease].
    Malamut G; Cellier C
    Rev Prat; 2008 Jun; 58(11):1199-205. PubMed ID: 18689116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.